Cancer Treatment firm Chlorogen has secured enough venture funding to continue research on a promising technique that kills cancerous cells using a substance from genetically modified tobacco plants. By manipulating chloroplast genes in tobacco leaves, they produce a protein that naturally exists in the human fetus known to eradicate cancer. However, when extracted from humans and grown in a animal cell culture the protein kills all surrounding organic material, hindering growth.

Developing a plant-based growth method would side-step this barrier and likely won't stoke the ire of groups against genetically engineered plants. These changes don't effect pollen, which would facilitate the transmission of altered DNA.

Once a regimen is perfected, Chlorogen anticipates it will be useful in treating ovarian, cervical, uterine, and prostate cancer.

Via (Red Herring)
Chlorogen